A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (AT3 ATAC-Seq)
Investigation and validation of genes that regulate CXCL9 expression by ATAC sequencing Overall design: AT3 cells were stimulated with IFNg/TNF.